SARS-CoV-2-Specific Antibody Prevalence and Symptoms in a Local Austrian Population

Frontiers in Medicine

Oliver Harzer¹  Dorothee Ladage²  Dennis Ladage³  Christoph Adler⁴  Yana Höglinger⁵  Israfil Yalcin⁶  Ralf J. Braun⁶ 

[1] Center of Biosciences, Danube Private University, Krems/Donau, Austria;Bioscientia, Institute of Medical Diagnostics, Ingelheim, Germany;Department of Internal Medicine, Danube Private University, Krems/Donau, Austria;Department of Internal Medicine, Danube Private University, Krems/Donau, Austria;Heart Center, University of Cologne, Cologne, Germany;Department of Pneumology, Kliniken Maria Hilf, Mönchengladbach, Germany;Department of Internal Medicine, Danube Private University, Krems/Donau, Austria;Heart Center, University of Cologne, Cologne, Germany;Fire Department, City of Cologne, Institute for Security Science and Rescue Technology, Cologne, Germany;Department of Internal Medicine, Danube Private University, Krems/Donau, Austria;Research Division for Neurodegenerative Diseases, Danube Private University, Krems/Donau, Austria;Research Division for Neurodegenerative Diseases, Danube Private University, Krems/Donau, Austria;

关键词: SARS-CoV-2;    COVID-19;    immunology & infectious diseases;    antibody prevalence;    disease symptom assessment;   

DOI  :  10.3389/fmed.2021.632942

来源: Frontiers

【 授权许可】

CC BY